Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

John A Thompson

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-NS General Operations
Phone303/724-8581
ORCID ORCID Icon0000-0003-2991-5194 Additional info

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Baumgartner AJ, Hirt L, Amara AW, Kern DS, Thompson JA. Diurnal fluctuations of subthalamic nucleus local field potentials follow naturalistic sleep-wake behavior in Parkinson's disease. Sleep. 2025 Jun 13; 48(6). PMID: 39798074.
      View in: PubMed
    2. Baumgartner AJ, Hirt L, Kern DS, Thompson JA. Anodic stimulation of the subthalamic nucleus rescues cathodic stimulation-induced mood symptoms in Parkinson disease. Brain Stimul. 2025 May 08; 18(4):1085-1087. PMID: 40340021.
      View in: PubMed
    3. Timmermann O, Ojemann SG, Thompson JA, Treat L, Kern DS. Case Report of Bilateral Subthalamic Nucleus Deep Brain Stimulation in an Adolescent TUBB4A Patient: She Can Sit on a Horse. Mov Disord Clin Pract. 2025 May 07. PMID: 40331309.
      View in: PubMed
    4. Platt JP, Radcliffe EM, Klimczak SL, Gliske SV, Kovach CK, Maroni D, Abosch A, Thompson JA. Multi-day recordings and adaptive stimulation protocols for in-home collection of deep brain stimulation intracranial recordings. J Neurosci Methods. 2025 Jun; 418:110442. PMID: 40188880.
      View in: PubMed
    5. Bayman E, Anigbogu C, Razmara A, Ojemann SG, Thompson JA, Kramer DR. Comparison of Deep Brain Stimulation and Responsive Neurostimulation Wound Complication Rates and Risk Factors: A Single-Center Retrospective Study. Stereotact Funct Neurosurg. 2025 Apr 04; 1-7. PMID: 40188819.
      View in: PubMed
    6. Satzer D, Kaye LC, Ojemann SG, Kramer DR, Thompson JA. Aperiodic activity as a biomarker of seizures and neuromodulation. Brain Stimul. 2025 May-Jun; 18(3):738-744. PMID: 40180220.
      View in: PubMed
    7. Satzer D, Kaye LC, Ryan MV, Ojemann SG, Thompson JA, Kramer DR. Mapping Healthy and Epileptic States in the Centromedian Nucleus Region. Neuromodulation. 2025 Mar 28. PMID: 40152848.
      View in: PubMed
    8. Pascual M, Bisarad P, Kelbert J, Chinander S, Gelineau-Morel R, Gorodetsky C, Hewitt AL, Larsh T, Lucente N, O'Malley J, Sanger TD, van der Werf L, Hauptman JS, Ponce FA, Kruer MC, Thompson JA. Stimulation-related increases in power spectral density covary with clinical evidence of overstimulation during deep brain stimulation for pediatric dystonia. medRxiv. 2025 Mar 07. PMID: 40093213.
      View in: PubMed
    9. Das R, Gliske SV, Maroni D, Situ-Kcomt M, West LC, Summers MO, Tang S, Vaswani PA, Halpern CH, Thompson JA, Kushida CA, Abosch A. Sleep spindle variation in patients with Parkinson's disease on first nights of sub-optimal deep brain stimulation. Clin Neurophysiol. 2025 Feb; 170:91-97. PMID: 39705860.
      View in: PubMed
    10. Kelbert J, Guest A, Bisarad P, Larsh TR, Bhatia P, Chinander S, Cornejo P, van der Werf L, Ponce FA, Thompson JA, Kruer MC. Local Field Potential-Based Programming for Deep Brain Stimulation in Pediatric DYT1 Dystonia. Mov Disord Clin Pract. 2025 Feb; 12(2):249-252. PMID: 39628113.
      View in: PubMed
    11. Martinez-Perez R, Casanova-Martinez D, Thompson JA, Hirt L, Kortz M, Labib MAM, Razmara A, Youssef AS. Circumferential exposure of the cavernous sinus and parasellar region through a combined open and endoscopic endonasal transcavernous approach, a morphometric study. Acta Neurochir (Wien). 2024 Oct 09; 166(1):399. PMID: 39382802.
      View in: PubMed
    12. Das R, Gliske SV, West LC, Summers MO, Tang S, Hirt L, Maroni D, Halpern CH, Thompson JA, Kushida CA, Abosch A. Sleep macro-architecture in patients with Parkinson's disease does not change during the first night of neurostimulation in a pilot study. J Clin Sleep Med. 2024 Sep 01; 20(9):1489-1496. PMID: 38652493.
      View in: PubMed
    13. Baker SK, Radcliffe EM, Kramer DR, Ojemann S, Case M, Zarns C, Holt-Becker A, Raike RS, Baumgartner AJ, Kern DS, Thompson JA. Comparison of beta peak detection algorithms for data-driven deep brain stimulation programming strategies in Parkinson's disease. NPJ Parkinsons Dis. 2024 Aug 09; 10(1):150. PMID: 39122725.
      View in: PubMed
    14. Ryan MV, Satzer D, Ojemann SG, Kramer DR, Thompson JA. Neurophysiologic Characteristics of the Anterior Nucleus of the Thalamus during Deep Brain Stimulation Surgery for Epilepsy. Stereotact Funct Neurosurg. 2024; 102(5):293-307. PMID: 39008968.
      View in: PubMed
    15. Sakai JT, Tanabe J, Battula S, Zipperly M, Mikulich-Gilbertson SK, Kern DS, Thompson JA, Raymond K, Gerecht PD, Foster K, Abosch A. Deep brain stimulation for the treatment of substance use disorders: a promising approach requiring caution. Front Psychiatry. 2024; 15:1435109. PMID: 39071229.
      View in: PubMed
    16. Bayman E, Chee K, Mendlen M, Denman DJ, Tien RN, Ojemann S, Kramer DR, Thompson JA. Subthalamic nucleus synchronization between beta band local field potential and single-unit activity in Parkinson's disease. Physiol Rep. 2024 May; 12(9):e16001. PMID: 38697943.
      View in: PubMed
    17. Freeman LM, Ung TH, Thompson JA, Ovard O, Olson M, Hirt L, Hosokawa P, Thaker A, Youssef AS. Refining the predictive value of preoperative apparent diffusion coefficient (ADC) by whole-tumor analysis for facial nerve outcomes in vestibular schwannomas. Acta Neurochir (Wien). 2024 Apr 05; 166(1):168. PMID: 38575773.
      View in: PubMed
    18. Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA. Short-Term Cannabidiol with ?-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Mov Disord. 2024 May; 39(5):863-875. PMID: 38487964.
      View in: PubMed
    19. Chee K, Hirt L, Mendlen M, Machnik J, Razmara A, Bayman E, Thompson JA, Kramer DR. Brain Shift during Staged Deep Brain Stimulation for Movement Disorders. Stereotact Funct Neurosurg. 2024; 102(2):83-92. PMID: 38286119.
      View in: PubMed
    20. Duffy KA, Fenstermacher EA, Thompson JA, Tanabe J, Patel MS, Ojemann S, Davis RA. Case report: Clinical efficacy of deep brain stimulation contacts corresponds to local field potential signals in a patient with obsessive-compulsive disorder. Front Psychiatry. 2023; 14:1279972. PMID: 38076699.
      View in: PubMed
    21. West LC, Summers M, Tang S, Hirt L, Halpern CH, Maroni D, Das R, Gliske SV, Abosch A, Kushida CA, Thompson JA. Evaluation of consensus sleep stage scoring of dysregulated sleep in Parkinson's disease. Sleep Med. 2023 07; 107:236-242. PMID: 37257366.
      View in: PubMed
    22. Ung TH, Freeman L, Hirt L, Kortz M, Belanger K, Baird-Daniel E, Hosokawa P, Thaker A, Thompson JA, Youssef AS. Surgical outcomes in large vestibular schwannomas: should cerebellopontine edema be considered in the grading systems? Acta Neurochir (Wien). 2023 07; 165(7):1749-1755. PMID: 37204532.
      View in: PubMed
    23. Radcliffe EM, Baumgartner AJ, Kern DS, Al Borno M, Ojemann S, Kramer DR, Thompson JA. Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease. J Neurophysiol. 2023 06 01; 129(6):1492-1504. PMID: 37198135.
      View in: PubMed
    24. Thompson JA, Hirt L, David-Gerecht P, Fasano A, Kramer DR, Ojemann SG, Kern DS. Comparison of Monopolar Review to Fixed Parameter Fractionation in Deep Brain Stimulation. Mov Disord Clin Pract. 2023 Jun; 10(6):987-991. PMID: 37332654.
      View in: PubMed
    25. Gault JM, Hosokawa P, Kramer D, Saks ER, Appelbaum PS, Thompson JA, Olincy A, Cascella N, Sawa A, Goodman W, Moukaddam N, Sheth SA, Anderson WS, Davis RA. Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder. Front Surg. 2023; 10:958452. PMID: 37066004.
      View in: PubMed
    26. Chee K, Razmara A, Geller AS, Harris WB, Restrepo D, Thompson JA, Kramer DR. Corrigendum: The role of the piriform cortex in temporal lobe epilepsy: A current literature review. Front Neurol. 2023; 14:1148230. PMID: 36908616.
      View in: PubMed
    27. Lewis S, Radcliffe E, Ojemann S, Kramer DR, Hirt L, Case M, Holt-Becker AB, Raike R, Kern DS, Thompson JA. Pilot Study to Investigate the Use of In-Clinic Sensing to Identify Optimal Stimulation Parameters for Deep Brain Stimulation Therapy in Parkinson's Disease. Neuromodulation. 2024 Apr; 27(3):509-519. PMID: 36797194.
      View in: PubMed
    28. McDermott D, Darwin ML, Fetrow K, Coulter I, Biesecker K, Thompson JA. Cannabis use patterns in drug-resistant and pharmacoresponsive epilepsy: Single tertiary referral center survey investigation. PLoS One. 2023; 18(1):e0281040. PMID: 36706124.
      View in: PubMed
    29. Chee K, Razmara A, Geller AS, Harris WB, Restrepo D, Thompson JA, Kramer DR. The role of the piriform cortex in temporal lobe epilepsy: A current literature review. Front Neurol. 2022; 13:1042887. PMID: 36479052.
      View in: PubMed
    30. Tekriwal A, Baker S, Christensen E, Petersen-Jones H, Tien RN, Ojemann SG, Kern DS, Kramer DR, Felsen G, Thompson JA. Quantifying neuro-motor correlations during awake deep brain stimulation surgery using markerless tracking. Sci Rep. 2022 10 27; 12(1):18120. PMID: 36302865.
      View in: PubMed
    31. Baker S, Tekriwal A, Felsen G, Christensen E, Hirt L, Ojemann SG, Kramer DR, Kern DS, Thompson JA. Automatic extraction of upper-limb kinematic activity using deep learning-based markerless tracking during deep brain stimulation implantation for Parkinson's disease: A proof of concept study. PLoS One. 2022; 17(10):e0275490. PMID: 36264986.
      View in: PubMed
    32. Serva SN, Bernstein J, Thompson JA, Kern DS, Ojemann SG. An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation. Front Surg. 2022; 9:863921. PMID: 36211256.
      View in: PubMed
    33. Kern D, Korsmo M, Baumgartner AJ, Kramer D, Ojemann S, Case M, Holt-Becker AB, Raike R, Thompson JA. Methylphenidate effects on a clinically informative oscillatory signal within the subthalamic nucleus in Parkinson's disease during deep brain stimulation programming. Brain Stimul. 2022 May-Jun; 15(3):747-749. PMID: 35526817.
      View in: PubMed
    34. Baumgartner AJ, Thompson JA, Kern DS, Ojemann SG. Novel targets in deep brain stimulation for movement disorders. Neurosurg Rev. 2022 Aug; 45(4):2593-2613. PMID: 35511309.
      View in: PubMed
    35. Hirt L, Kern DS, Ojemann S, Grassia F, Kramer D, Thompson JA. Use of Three-Dimensional Printed Brain Models During Deep Brain Stimulation Surgery Consultation for Patient Health Literacy: A Randomized Controlled Investigation. World Neurosurg. 2022 06; 162:e526-e533. PMID: 35306197.
      View in: PubMed
    36. Tekriwal A, Felsen G, Ojemann SG, Abosch A, Thompson JA. Motor context modulates substantia nigra pars reticulata spike activity in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2022 04; 93(4):386-394. PMID: 35193951.
      View in: PubMed
    37. Hirt L, Grassia F, Feuerstein J, Thompson JA, Ojemann S, Kern DS. Deep Brain Stimulation of the Ventral Intermediate Nucleus of the Thalamus in Writer's Cramp: A Case Report. Tremor Other Hyperkinet Mov (N Y). 2021; 11:46. PMID: 34824889.
      View in: PubMed
    38. Baumgartner AJ, Kushida CA, Summers MO, Kern DS, Abosch A, Thompson JA. Basal Ganglia Local Field Potentials as a Potential Biomarker for Sleep Disturbance in Parkinson's Disease. Front Neurol. 2021; 12:765203. PMID: 34777232.
      View in: PubMed
    39. Murcia D, D'Souza S, Abozeid M, Thompson JA, Djoyum TD, Ormond DR. Investigation of Asleep versus Awake Motor Mapping in Resective Brain Surgery. World Neurosurg. 2022 01; 157:e129-e136. PMID: 34619401.
      View in: PubMed
    40. Tekriwal A, Lintz MJ, Thompson JA, Felsen G. Disrupted basal ganglia output during movement preparation in hemiparkinsonian mice is consistent with behavioral deficits. J Neurophysiol. 2021 10 01; 126(4):1248-1264. PMID: 34406873.
      View in: PubMed
    41. Ung TH, Kahn L, Hirt L, Chatain G, Humes E, David-Gerecht P, Drees C, Thompson JA, Ojemann S, Abosch A. Using a Robotic-Assisted Approach for Stereotactic Laser Ablation Corpus Callosotomy: A Technical Report. Stereotact Funct Neurosurg. 2022; 100(1):61-66. PMID: 34515241.
      View in: PubMed
    42. Fringuello A, Tatman PD, Wroblewski T, Thompson JA, Yu X, Lillehei KO, Kowalski RG, Graner MW. Cytokine-Laden Extracellular Vesicles Predict Patient Prognosis after Cerebrovascular Accident. Int J Mol Sci. 2021 Jul 22; 22(15). PMID: 34360613.
      View in: PubMed
    43. Thaker AA, Reddy KM, Thompson JA, Gerecht PD, Brown MS, Abosch A, Ojemann SG, Kern DS. Coronal Gradient Echo MRI to Visualize the Zona Incerta for Deep Brain Stimulation Targeting in Parkinson's Disease. Stereotact Funct Neurosurg. 2021; 99(5):443-450. PMID: 33902054.
      View in: PubMed
    44. Kahn L, Sutton B, Winston HR, Abosch A, Thompson JA, Davis RA. Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval. Front Psychiatry. 2021; 12:568932. PMID: 33868034.
      View in: PubMed
    45. Belanger K, Grassia F, Kortz MW, Thompson JA, DeStefano S, Ojemann S. Management of post-operative delirium following stereoelectroencephalography electrode placement for drug resistant epilepsy: Lessons learned from two case reports. Epilepsy Behav Rep. 2021; 16:100438. PMID: 33997756.
      View in: PubMed
    46. D'Souza S, Hirt L, Ormond DR, Thompson JA. Retrospective analysis of hemispheric structural network change as a function of location and size of glioma. Brain Commun. 2021; 3(1):fcaa216. PMID: 33501423.
      View in: PubMed
    47. Kern DS, Fasano A, Thompson JA, Abosch A, Ojemann S, Munhoz RP. Constant Current versus Constant Voltage: Clinical Evidence Supporting a Fundamental Difference in the Modalities. Stereotact Funct Neurosurg. 2021; 99(2):171-175. PMID: 33227781.
      View in: PubMed
    48. Youssef AS, Arnone GD, Farell NF, Thompson JA, Ramakrishnan VR, Gubbels S, Cohen-Gadol AA, Cass S, Labib MA. The Combined Endoscopic Endonasal Far Medial and Open Postauricular Transtemporal Approaches As a Lesser Invasive Approach to the Jugular Foramen: Anatomic Morphometric Study With Case Illustration. Oper Neurosurg (Hagerstown). 2020 09 15; 19(4):471-479. PMID: 32510567.
      View in: PubMed
    49. Kern DS, Uy D, Rhoades R, Ojemann S, Abosch A, Thompson JA. Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2020 09; 91(9):928-937. PMID: 32651244.
      View in: PubMed
    50. George DD, Ojemann SG, Drees C, Thompson JA. Stimulation Mapping Using Stereoelectroencephalography: Current and Future Directions. Front Neurol. 2020; 11:320. PMID: 32477236.
      View in: PubMed
    51. Gault JM, Thompson JA, Maharajh K, Hosokawa P, Stevens KE, Olincy A, Liedtke EI, Ojemann A, Ojemann S, Abosch A. Striatal and Thalamic Auditory Response During Deep Brain Stimulation for Essential Tremor: Implications for Psychosis. Neuromodulation. 2020 Jun; 23(4):478-488. PMID: 32022409.
      View in: PubMed
    52. Pang Y, Christenson J, Jiang F, Lei T, Rhoades R, Kern D, Thompson JA, Liu C. Automatic detection and quantification of hand movements toward development of an objective assessment of tremor and bradykinesia in Parkinson's disease. J Neurosci Methods. 2020 03 01; 333:108576. PMID: 31923452.
      View in: PubMed
    53. D'Souza S, Ormond DR, Costabile J, Thompson JA. Fiber-tract localized diffusion coefficients highlight patterns of white matter disruption induced by proximity to glioma. PLoS One. 2019; 14(11):e0225323. PMID: 31751402.
      View in: PubMed
    54. Costabile JD, Thompson JA, Alaswad E, Ormond DR. Biopsy Confirmed Glioma Recurrence Predicted by Multi-Modal Neuroimaging Metrics. J Clin Med. 2019 Aug 23; 8(9). PMID: 31450732.
      View in: PubMed
    55. Tekriwal A, Afshar NM, Santiago-Moreno J, Kuijper FM, Kern DS, Halpern CH, Felsen G, Thompson JA. Neural Circuit and Clinical Insights from Intraoperative Recordings During Deep Brain Stimulation Surgery. Brain Sci. 2019 Jul 20; 9(7). PMID: 31330813.
      View in: PubMed
    56. Costabile JD, Alaswad E, D'Souza S, Thompson JA, Ormond DR. Current Applications of Diffusion Tensor Imaging and Tractography in Intracranial Tumor Resection. Front Oncol. 2019; 9:426. PMID: 31192130.
      View in: PubMed
    57. Kern DS, Picillo M, Thompson JA, Sammartino F, di Biase L, Munhoz RP, Fasano A. Interleaving Stimulation in Parkinson's Disease, Tremor, and Dystonia. Stereotact Funct Neurosurg. 2018; 96(6):379-391. PMID: 30654368.
      View in: PubMed
    58. Christensen E, Abosch A, Thompson JA, Zylberberg J. Inferring sleep stage from local field potentials recorded in the subthalamic nucleus of Parkinson's patients. J Sleep Res. 2019 08; 28(4):e12806. PMID: 30549130.
      View in: PubMed
    59. Winter M, Costabile JD, Abosch A, Thompson JA. Method for localizing intraoperative recordings from deep brain stimulation surgery using post-operative structural MRI. Neuroimage Clin. 2018; 20:1123-1128. PMID: 30380519.
      View in: PubMed
    60. Weinkle LJ, Hoyt B, Thompson JA, Sillau S, Tanabe J, Honce J, Klepitskaya O. Association of MRI Measurements with Cognitive Outcomes After STN-DBS in Parkinson's Disease. Mov Disord Clin Pract. 2018 Jul-Aug; 5(4):417-426. PMID: 30363383.
      View in: PubMed
    61. Thompson JA, Oukal S, Bergman H, Ojemann S, Hebb AO, Hanrahan S, Israel Z, Abosch A. Semi-automated application for estimating subthalamic nucleus boundaries and optimal target selection for deep brain stimulation implantation surgery. J Neurosurg. 2018 May 18; 130(4):1224-1233. PMID: 29775152.
      View in: PubMed
    62. Tekriwal A, Felsen G, Thompson JA. Modular auditory decision-making behavioral task designed for intraoperative use in humans. J Neurosci Methods. 2018 07 01; 304:162-167. PMID: 29746889.
      View in: PubMed
    63. Vasquez CA, Thompson JA, Youssef AS. The Tentorial Bridge to Deep Skull Base Exposure: Anatomic Morphometric Study. World Neurosurg. 2018 Jun; 114:e588-e596. PMID: 29551719.
      View in: PubMed
    64. Gault JM, Davis R, Cascella NG, Saks ER, Corripio-Collado I, Anderson WS, Olincy A, Thompson JA, Pomarol-Clotet E, Sawa A, Daskalakis ZJ, Lipsman N, Abosch A. Approaches to neuromodulation for schizophrenia. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):777-787. PMID: 29242310.
      View in: PubMed
    65. Brown MG, Drees C, Nagae LM, Thompson JA, Ojemann S, Abosch A. Curative and palliative MRI-guided laser ablation for drug-resistant epilepsy. J Neurol Neurosurg Psychiatry. 2018 Apr; 89(4):425-433. PMID: 29084870.
      View in: PubMed
    66. Ormond DR, D'Souza S, Thompson JA. Global and Targeted Pathway Impact of Gliomas on White Matter Integrity Based on Lobar Localization. Cureus. 2017 Sep 07; 9(9):e1660. PMID: 29147635.
      View in: PubMed
    67. Thompson JA, Tekriwal A, Felsen G, Ozturk M, Telkes I, Wu J, Ince NF, Abosch A. Sleep patterns in Parkinson's disease: direct recordings from the subthalamic nucleus. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):95-104. PMID: 28866626.
      View in: PubMed
    68. Thompson JA, Yin D, Ojemann SG, Abosch A. Use of the Putamen as a Surrogate Anatomical Marker for the Internal Segment of the Globus Pallidus in Deep Brain Stimulation Surgery. Stereotact Funct Neurosurg. 2017; 95(4):229-235. PMID: 28728152.
      View in: PubMed
    69. Kolb R, Abosch A, Felsen G, Thompson JA. Use of intraoperative local field potential spectral analysis to differentiate basal ganglia structures in Parkinson's disease patients. Physiol Rep. 2017 Jun; 5(12). PMID: 28642341.
      View in: PubMed
    70. Yin D, Thompson JA, Drees C, Ojemann SG, Nagae L, Pelak VS, Abosch A. Optic Radiation Tractography and Visual Field Deficits in Laser Interstitial Thermal Therapy for Amygdalohippocampectomy in Patients with Mesial Temporal Lobe Epilepsy. Stereotact Funct Neurosurg. 2017; 95(2):107-113. PMID: 28324881.
      View in: PubMed
    71. Tekriwal A, Kern DS, Tsai J, Ince NF, Wu J, Thompson JA, Abosch A. REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017 05; 88(5):445-451. PMID: 27965397.
      View in: PubMed
    72. Liedtke EI, Zhang S, Thompson JA, Sillau S, Gault J. Correlated expression analysis of genes implicated in schizophrenia: identification of putative disease-related pathways. New Horiz Transl Med. 2017 Jan; 3(5):224-232. PMID: 32864408.
      View in: PubMed
    73. Dondzillo A, Thompson JA, Klug A. Recurrent Inhibition to the Medial Nucleus of the Trapezoid Body in the Mongolian Gerbil (Meriones Unguiculatus). PLoS One. 2016; 11(8):e0160241. PMID: 27489949.
      View in: PubMed
    74. Thompson JA, Costabile JD, Felsen G. Mesencephalic representations of recent experience influence decision making. Elife. 2016 07 25; 5. PMID: 27454033.
      View in: PubMed
    75. Stratford JM, Thompson JA. MSG-Evoked c-Fos Activity in the Nucleus of the Solitary Tract Is Dependent upon Fluid Delivery and Stimulation Parameters. Chem Senses. 2016 Mar; 41(3):211-20. PMID: 26762887.
      View in: PubMed
    76. Wolf AB, Lintz MJ, Costabile JD, Thompson JA, Stubblefield EA, Felsen G. An integrative role for the superior colliculus in selecting targets for movements. J Neurophysiol. 2015 Oct; 114(4):2118-31. PMID: 26203103.
      View in: PubMed
    77. Stubblefield EA, Thompson JA, Felsen G. Optogenetic cholinergic modulation of the mouse superior colliculus in vivo. J Neurophysiol. 2015 Aug; 114(2):978-88. PMID: 26019317.
      View in: PubMed
    78. Stratford JM, Thompson JA. Beta-galactosidase staining in the nucleus of the solitary tract of Fos-Tau-LacZ mice is unaffected by monosodium glutamate taste stimulation. PLoS One. 2014; 9(9):e107238. PMID: 25192442.
      View in: PubMed
    79. Thompson JA, Lanctin D, Ince NF, Abosch A. Clinical implications of local field potentials for understanding and treating movement disorders. Stereotact Funct Neurosurg. 2014; 92(4):251-63. PMID: 25170784.
      View in: PubMed
    80. Albrecht O, Dondzillo A, Mayer F, Thompson JA, Klug A. Inhibitory projections from the ventral nucleus of the trapezoid body to the medial nucleus of the trapezoid body in the mouse. Front Neural Circuits. 2014; 8:83. PMID: 25120436.
      View in: PubMed
    81. Tyagi A, Raina K, Shrestha SP, Miller B, Thompson JA, Wempe MF, Agarwal R, Agarwal C. Procyanidin B2 3,3(?)-di-O-gallate, a biologically active constituent of grape seed extract, induces apoptosis in human prostate cancer cells via targeting NF-?B, Stat3, and AP1 transcription factors. Nutr Cancer. 2014; 66(4):736-46. PMID: 24191894.
      View in: PubMed
    82. Thompson JA, Felsen G. Activity in mouse pedunculopontine tegmental nucleus reflects action and outcome in a decision-making task. J Neurophysiol. 2013 Dec; 110(12):2817-29. PMID: 24089397.
      View in: PubMed
    83. Shrestha SP, Thompson JA, Wempe MF, Gu M, Agarwal R, Agarwal C. Glucuronidation and methylation of procyanidin dimers b2 and 3,3?-di-o-galloyl-b2 and corresponding monomers epicatechin and 3-o-galloyl-epicatechin in mouse liver. Pharm Res. 2012 Mar; 29(3):856-65. PMID: 22068277.
      View in: PubMed
    84. Shearn CT, Fritz KS, Thompson JA. Protein damage from electrophiles and oxidants in lungs of mice chronically exposed to the tumor promoter butylated hydroxytoluene. Chem Biol Interact. 2011 Jul 15; 192(3):278-86. PMID: 21536018.
      View in: PubMed
    85. Thompson JA, Perkel DJ. Endocannabinoids mediate synaptic plasticity at glutamatergic synapses on spiny neurons within a basal ganglia nucleus necessary for song learning. J Neurophysiol. 2011 Mar; 105(3):1159-69. PMID: 21177997.
      View in: PubMed
    86. Shearn CT, Fritz KS, Meier BW, Kirichenko OV, Thompson JA. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. Chem Res Toxicol. 2008 Aug; 21(8):1631-41. PMID: 18597497.
      View in: PubMed
    87. Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. Invest New Drugs. 2006 Jan; 24(1):89-94. PMID: 16379038.
      View in: PubMed
    Thompson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (264) concept(s)
    _
    Co-Authors Expand Description
    See all (54) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)